The Silent Pandemic: How Sporothrix brasiliensis Is Rewriting the Rules of Fungal Disease

Executive Summary

A previously obscure fungal pathogen called Sporothrix brasiliensis is causing one of the largest zoonotic fungal outbreaks ever recorded, with more than 11,000 human cases and thousands of feline deaths documented across South America since it emerged in Brazil in the 1990s. What makes this outbreak unprecedented is not just the scale—it is the mechanism. Unlike nearly all other fungal pathogens, which require environmental reservoirs or soil contact to spread, S. brasiliensis can transmit directly from cat to cat and from cats to humans via scratches, bites, and even casual contact. The U.S. Centers for Disease Control and Prevention (CDC) has issued formal warnings, and senior agency officials have stated that it is “just a matter of time” before the pathogen arrives in the United States Science News. With a 70% fatality rate in untreated human patients and near 100% mortality in untreated cats, no effective vaccine, prolonged treatment courses lasting 3–4 months for cutaneous disease and at least a year for pulmonary or disseminated forms, and emerging treatment-failure cases, this outbreak represents a major—and still underrecognized—global public health threat.

The Pathogen at the Center of the Storm

The fungus driving this epidemic belongs to the genus Sporothrix, a group of dimorphic fungi long associated with the classic “rose gardener's disease.” Historically, Sporothrix schenckii was the best-known member of the genus, causing sporotrichosis—typically a chronic, granulomatous skin infection—after traumatic inoculation from thorns, hay, or sphagnum moss MSD Veterinary Manual. But S. brasiliensis is different in ways that have caught the global medical community off guard.

What distinguishes S. brasiliensis from its relatives is a combination of high virulence, thermal tolerance, and—most remarkably—the ability to sustain direct mammalian-to-mammalian transmission. Peer-reviewed research led by Dr. Anderson Messias Rodrigues at the Federal University of São Paulo is now characterizing how the pathogen is evolving genetically as it spreads, providing critical insights into why this species has become so dangerous EurekAlert. The high fungal burden in feline lesions appears to be a key biological driver of the transmission chain: sick cats shed enormous quantities of yeast cells, which then infect other cats or humans through even minor contact Nature Scientific Reports.

The World Health Organization has now classified sporotrichosis as a neglected tropical disease, citing the cat-associated outbreak as a public health priority WHO. That designation marks a significant shift in how the international community views what was once considered a niche occupational hazard of gardeners and farmers.

Geographic Spread: From Rio to the World

The outbreak traces its origins to Rio de Janeiro in the late 1990s, when veterinarians first began noticing an unusual cluster of feline sporotrichosis cases. From that initial foothold, the pathogen has spread relentlessly. Today, it is firmly established across Brazil and has crossed borders into Paraguay, Chile, Argentina, and Uruguay Science News. The documented expansion into Uruguay is particularly alarming: the fungus was identified there only after a 2025 family outbreak, and has since been detected in additional sick cats in the Maldonado and Rocha departments, suggesting that local transmission chains are now established Ecoticias.

A study published in Emerging Infectious Diseases documenting the rising incidence in Curitiba, Brazil, provides one of the clearest case studies of how rapidly S. brasiliensis can establish itself in an urban setting. Year-over-year increases in both feline and human cases reveal a pathogen that exploits dense cat populations, fragmented veterinary care, and socioeconomic vulnerabilities CDC EID – Curitiba. At least 200 dogs have also been infected during the outbreak, illustrating that while cats are the primary reservoir, other companion animals are not spared Science News.

The pathogen has now been documented outside South America. The first three reported cases of cat-transmitted S. brasiliensis sporotrichosis outside the continent were identified in the United Kingdom, prompting the CDC to issue a formal warning EveryCat Foundation; DVM360. Two of the cases occurred in members of a household that had relocated from Brazil three years prior, both developing skin lesions that resolved with antifungal treatment; the third was a veterinarian who was separately infected while treating another imported cat at a clinic. A separate clonal household outbreak documented in Mycopathologia further illustrates how a single infected animal can seed infection in humans, other cats, and dogs within a domestic environment Springer/Mycopathologia.

Closer to the United States, a cluster of feline sporotrichosis cases has already been identified in Kansas—although, notably, these cases were caused by Sporothrix schenckii rather than S. brasiliensis. The cluster involved two domestic cats and one veterinary technician who was infected through a puncture wound while caring for an affected cat, underscoring the broader zoonotic potential of the Sporothrix genus in North America NBC News; CDC EID – Kansas Cluster. CDC fungal diseases division chief Dr. Tom Chiller's warning that S. brasiliensis reaching the United States is “just a matter of time” carries weight precisely because the infrastructure for cat-to-human fungal transmission already exists in many U.S. communities.

Transmission Dynamics: A Fungal Pathogen That Behaves Like a Virus

The biology of S. brasiliensis sets it apart from virtually every other fungal pathogen of public health significance. Most fungi causing human disease—Histoplasma, Coccidioides, Blastomyces—are acquired from the environment, typically by inhalation of spores from soil or organic matter. Sporotrichosis has traditionally followed that pattern, with traumatic inoculation from plant material being the classic route.

S. brasiliensis has broken that mold. According to multiple sources, the fungus spreads through several routes that are highly unusual for a fungal organism Science News:

The MSD Veterinary Manual emphasizes that “cats play a central role in the zoonotic transmission of Sporothrix infection, particularly in Latin America,” a statement that reflects decades of accumulated clinical experience MSD Veterinary Manual. Veterinarians, veterinary technicians, animal shelter workers, and cat owners are at particularly elevated occupational risk—a danger underscored not only by the South American experience but also by the Kansas veterinary technician cluster WHO; CDC EID – Kansas Cluster.

The implications of this transmission pattern are profound. A pathogen that can spread through casual contact between mammals fundamentally changes the calculus of outbreak control. Quarantine, isolation of infected animals, and rigorous hygiene become essential—and yet, as WHO notes, there are currently no effective preventive measures beyond early identification and treatment of infected cats WHO.

Clinical Presentation: What the Disease Looks Like in Cats and Humans

In Cats

Feline sporotrichosis caused by S. brasiliensis is a severe, multi-system disease. Infected cats typically develop oozing skin ulcers, swollen lymph nodes, and—distinctively for this species—severe respiratory involvement MSD Veterinary Manual; Nature Scientific Reports. Lesions often begin at the site of inoculation—typically the face or forelimbs, where bites and scratches are common—and progress rapidly. Nasal and respiratory symptoms reflect the predilection of S. brasiliensis for mucosal tissues, a feature that also enhances its transmissibility via sneezing.

Without treatment, the infection carries a near 100% fatality rate in cats Science News. This grim prognosis has made feline cases not just a veterinary concern but a sentinel event for public health authorities, signaling ongoing zoonotic risk.

In Humans

In people, sporotrichosis most commonly presents as a cutaneous infection at the site of inoculation. After a scratch or bite from an infected cat, painful skin lesions develop—often starting as small papules or nodules that ulcerate and fail to heal CDC Sporotrichosis Basics; Cleveland Clinic. Because these lesions resemble other common conditions—bacterial skin infections, spider bites, even cutaneous leishmaniasis—diagnosis is frequently delayed, particularly in regions where sporotrichosis has not historically been common.

When the infection disseminates, the consequences can be devastating. Rare but severe forms include arthritis, pulmonary sporotrichosis (acquired by inhaling spores, presenting with cough, shortness of breath, and fever), and meningitis Ecoticias; WHO; Cleveland Clinic. These disseminated forms are particularly dangerous for young children, older adults, and immunocompromised individuals. The CDC reports a 70% fatality rate in untreated patients overall News Directory 3—a figure that should give pause to any clinician encountering a suspicious skin lesion in a patient with cat exposure.

Treatment, Treatment Failures, and the Prevention Gap

There is currently no vaccine for S. brasiliensis, and no effective preventive measures beyond early identification and treatment of infected cats, according to the WHO WHO. Treatment courses vary by disease severity: cutaneous infections typically require several months of oral antifungal medication, while pulmonary or disseminated disease requires at least a year of treatment including intravenous amphotericin B—conditions that are difficult to meet in resource-limited settings or among lower-income pet owners, who are often disproportionately affected by the outbreak.

Even more concerning are emerging reports of treatment failure. A study documented in Emerging Infectious Diseases found that among 108 feline isolates from the Brazil–Paraguay–Argentina border region, MIC levels for most antifungal agents were low, yet refractory clinical cases still occurred—suggesting that conventional laboratory susceptibility testing may not reliably predict clinical outcomes CDC EID. This introduces a troubling degree of uncertainty into clinical decision-making.

The prevention gap is significant. With no vaccine, no post-exposure prophylaxis, and the pathogen's ability to persist in the environment for weeks, control efforts have focused on a One Health approach: rapid identification and treatment of infected animals, public education about the risks of handling sick cats, and collaboration between medical and veterinary teams. The CDC has held dedicated teleconferences to alert clinicians and veterinarians to the threat DVM360—an unusual step that reflects the seriousness with which the agency is treating the situation.

Emerging Research and Future Directions

The scientific response to S. brasiliensis is accelerating. A 2025 review article highlights the promising potential of veterinary vaccination as a strategy to protect both cats and humans: by reducing the feline reservoir of infection, vaccination could interrupt the zoonotic cycle at its source Springer. The logic is straightforward—if you cannot easily prevent human exposure to free-roaming cats, you can at least reduce the pathogen load those cats carry.

The Rodrigues laboratory at the Federal University of São Paulo continues to lead efforts to characterize how S. brasiliensis is evolving genetically, work that may help explain the pathogen's unusual transmissibility and identify new therapeutic targets EurekAlert. The CDC's Fungal Diseases Spotlight in Emerging Infectious Diseases is providing ongoing surveillance of the geographic expansion of Sporothrix species, tracking both the Brazilian S. brasiliensis epidemic and the emergence of cat-associated clusters in North America CDC EID – Fungal Spotlight.

Broader Context: A Fungal World in Transition

S. brasiliensis is not the only fungal pathogen capable of infecting both cats and humans. Blastomycosis, for instance, is a primarily respiratory infection acquired by inhalation that commonly affects both species, with cats among the most commonly affected Merck Veterinary Manual. What distinguishes S. brasiliensis from these other pathogens—and what makes the current South American outbreak uniquely dangerous—is its efficient direct mammalian-to-mammalian transmission.

That distinction matters enormously for public health planning. A fungus that requires environmental exposure can be controlled by modifying the environment; a fungus that spreads cat-to-cat and cat-to-human requires fundamentally different interventions, centered on animal health, veterinary infrastructure, and community education. The Kansas cluster, caused by the related but less virulent S. schenckii, demonstrates that even milder Sporothrix species can cross the species barrier in domestic settings NBC News. The implications extend beyond this single outbreak: the world is witnessing a broader pattern of fungal emergence driven by climate change, global trade, and shifting patterns of human-animal contact, and S. brasiliensis is the leading edge of that wave.

Public Health Significance and the Road Ahead

The ongoing S. brasiliensis epidemic represents a convergence of factors that public health experts have long warned about: a virulent pathogen, an efficient mammalian reservoir, environmental persistence, expanding geographic range, and limited treatment options. The fact that it has already crossed the South American continent and seeded outbreaks elsewhere should be a wake-up call for global health agencies.

What makes the situation particularly urgent is the pathogen's ability to spread silently. The UK cases—in which two household members developed symptoms three years after relocating from Brazil—illustrate how easily S. brasiliensis can move across borders undetected Science News; EveryCat Foundation. The Uruguayan family outbreak of 2025 and the first documented cases outside South America confirm that the pathogen's range is no longer confined to a single continent Ecoticias; EveryCat Foundation. The rising urban incidence documented in Curitiba serves as a template for what could happen in cities around the world if surveillance and response are not strengthened CDC EID – Curitiba.

For the United States, the warning from CDC's fungal diseases leadership is clear: the pathogen will arrive, and the question is whether the country will be ready. That means investing in veterinary and medical surveillance, funding research into vaccines and improved therapies, educating clinicians to recognize the early signs of sporotrichosis, and addressing the socioeconomic conditions that allow zoonotic outbreaks to flourish in the first place.

Conclusion

To directly answer the question: yes, a deadly fungus that can jump between cats and people is genuinely spreading, and researchers are rightly concerned. Sporothrix brasiliensis is driving a zoonotic epidemic of historic proportions—one that has killed thousands of cats, infected more than 11,000 people across South America, and is now breaking out of its original geographic confines. Its unique capacity for direct mammalian-to-mammalian transmission, combined with high virulence, environmental persistence, prolonged treatment requirements, and emerging treatment failures, has earned it the attention of the WHO, the CDC, and leading mycology research laboratories worldwide. The pathogen is not a hypothetical threat; it is a present-tense crisis that is already on the move. The 11,000+ human cases in South America, the documented outbreaks in Uruguay and the United Kingdom, and the recent warning that arrival in the United States is “just a matter of time” all point to the same conclusion: S. brasiliensis is a pathogen the world can no longer afford to ignore.

Sources

-Jens